Does methotrexate (MTX) affect menstruation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Methotrexate's Effects on Menstruation

Yes, methotrexate can affect menstruation, potentially causing menstrual abnormalities including amenorrhea in some patients. This effect appears to be related to both cumulative dose and duration of therapy, with higher disease activity also being a significant factor 1.

Mechanisms of Menstrual Effects

Methotrexate may affect menstruation through several mechanisms:

  • Impact on ovarian function: As a folate antagonist, methotrexate targets rapidly dividing cells, which can include ovarian cells 1
  • Hormonal changes: Studies have shown that FSH levels have a significant positive correlation with cumulative methotrexate dose and duration of therapy 1
  • Diminished ovarian reserve: Higher levels of FSH, which indicate diminished ovarian reserve, are associated with disease activity, cumulative dose, and duration of methotrexate therapy 1

Clinical Presentation

Menstrual abnormalities associated with methotrexate may include:

  • Secondary amenorrhea: Complete absence of menstruation after previous normal cycles 2
  • Irregular cycles: Changes in frequency, duration, or flow of menstruation
  • Menopausal symptoms: Over 50% of patients in some studies report menopausal symptoms, particularly hot flushes 1

Risk Factors

Factors that may increase the risk of menstrual abnormalities with methotrexate include:

  • Higher disease activity: Multivariate analysis showed disease activity (DAS 28) was significantly associated with FSH levels 1
  • Longer duration of therapy: Significant positive correlation with FSH levels 1
  • Higher cumulative dose: Significant positive correlation with FSH levels 1
  • Older age: Menstrual abnormalities are more likely to occur in older premenopausal patients 3

Management Considerations

For patients experiencing menstrual abnormalities while on methotrexate:

  • Monitor reproductive hormones: Consider checking FSH and LH levels if menstrual abnormalities occur
  • Pregnancy considerations: Methotrexate is absolutely contraindicated during pregnancy due to its teratogenic effects 4, 5
  • Contraception requirements: Effective contraception must be used while taking methotrexate 4
  • Discontinuation timing: Women should discontinue methotrexate at least 3 months before attempting conception 4

Important Caveats

  • Reversibility: Some menstrual abnormalities may be reversible after discontinuation of methotrexate, though data is limited
  • Individual variation: Not all patients will experience menstrual changes
  • Confounding factors: Underlying disease activity may independently contribute to menstrual abnormalities

Clinical Implications

For women of reproductive age taking methotrexate:

  • Counsel about potential menstrual changes before starting therapy
  • Monitor menstrual patterns during treatment
  • Remember that methotrexate is contraindicated in pregnancy and requires effective contraception 4
  • If pregnancy is desired, discontinue methotrexate at least 3 months before attempting conception 4

In summary, methotrexate can affect menstruation through its impact on ovarian function and hormone levels, with effects potentially related to dose, duration, and disease activity. Healthcare providers should monitor and counsel patients accordingly.

References

Research

Unexplained amenorrhea in a patient taking methotrexate for the treatment of rheumatoid arthritis.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2010

Research

The risk of premature menopause induced by chemotherapy for early breast cancer.

Journal of women's health & gender-based medicine, 1999

Guideline

Reproductive Health and Methotrexate

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.